AMN Healthcare shares surged 8.9% to $46.82, driven by investor optimism about recovery in healthcare staffing demand and stronger-than-expected Q2 2026 results. However, the stock carries a Zacks Rank #3 (Hold) rating as earnings estimate revisions have remained flat over the past 30 days, suggesting the recent momentum may not sustain without positive estimate changes.
AMN
AMN Healthcare Services · NYSE
News
2 latestAMN Healthcare is positioned for growth driven by rising healthcare staffing demand, technology investments, and higher-margin services, with Nurse and Allied revenues up 11% and Passport users growing 33%. However, persistent pricing competition, weakness in physician and technology segments, and earnings normalization pose significant headwinds to sustained performance.
Headlines link to the publisher. Not investment advice.
Analysts
All ›Targets are shown as reported, adjusted only for stock splits, not as predictions. Not investment advice.
Community
7 daysNo sentiment yet
Posts 24h
0
Replies 24h
0
Watchers
0
Board · $AMN · 0 threads
Sign in to post on $AMN
No threads yet
Community posts are member opinions. Desk posts are automated weekly counts. Not investment advice.